Literature DB >> 25382874

Inorganic chemistry in nuclear imaging and radiotherapy: current and future directions.

Valerie Carroll1, Dustin W Demoin1, Timothy J Hoffman2, Silvia S Jurisson1.   

Abstract

Radiometals play anpan> importanpan>t role inpan> diagnostic anpan>d therapeutic radiopharmaceuticals. This field of radiochemistry is multidisciplinpan>ary, inpan>volvinpan>g radiopan> class="Chemical">metal production, separation of the radiometal from its target, chelate design for complexing the radiometal in a biologically stable environment, specific targeting of the radiometal to its in vivo site, and nuclear imaging and/or radiotherapy applications of the resultant radiopharmaceutical. The critical importance of inorganic chemistry in the design and application of radiometal-containing imaging and therapy agents is described from a historical perspective to future directions.

Entities:  

Keywords:  Bifunctional chelates; Nuclear imaging; Radiometals; Radiotherapy; Specific targeting

Year:  2012        PMID: 25382874      PMCID: PMC4221859          DOI: 10.1524/ract.2012.1964

Source DB:  PubMed          Journal:  Radiochim Acta        ISSN: 0033-8230            Impact factor:   1.440


  131 in total

1.  99mTc-Labeled Small Peptides as Diagnostic Radiopharmaceuticals.

Authors:  S Liu; D S Edwards
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

Review 2.  Positron-emitting isotopes produced on biomedical cyclotrons.

Authors:  Paul McQuade; Douglas J Rowland; Jason S Lewis; Michael J Welch
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

3.  Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals.

Authors:  Sibaprasad Bhattacharyya; Manish Dixit
Journal:  Dalton Trans       Date:  2011-05-03       Impact factor: 4.390

4.  Efficient bifunctional gallium-68 chelators for positron emission tomography: tris(hydroxypyridinone) ligands.

Authors:  David J Berry; Yongmin Ma; James R Ballinger; Richard Tavaré; Alexander Koers; Kavitha Sunassee; Tao Zhou; Saima Nawaz; Gregory E D Mullen; Robert C Hider; Philip J Blower
Journal:  Chem Commun (Camb)       Date:  2011-05-27       Impact factor: 6.222

5.  Biodistribution of model 105Rh-labeled tetradentate thiamacrocycles in rats.

Authors:  N Li; M Struttman; C Higginbotham; A J Grall; J F Skerlj; J F Vollano; S A Bridger; L A Ochrymowycz; A R Ketring; M J Abrams; W A Volkert
Journal:  Nucl Med Biol       Date:  1997-01       Impact factor: 2.408

Review 6.  New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and a strategy for new chelate design.

Authors:  Sangeeta Ray Banerjee; Kevin P Maresca; Lynn Francesconi; John Valliant; John W Babich; Jon Zubieta
Journal:  Nucl Med Biol       Date:  2005-01       Impact factor: 2.408

7.  89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo.

Authors:  Jason P Holland; Vadim Divilov; Neil H Bander; Peter M Smith-Jones; Steven M Larson; Jason S Lewis
Journal:  J Nucl Med       Date:  2010-07-21       Impact factor: 10.057

Review 8.  Peptide-based radiopharmaceuticals and cytotoxic conjugates: potential tools against cancer.

Authors:  S M Okarvi
Journal:  Cancer Treat Rev       Date:  2007-09-17       Impact factor: 12.111

9.  Subcellular distribution and metabolism studies of the potential myocardial imaging agent [99mTc(N)(DBODC)(PNP5)]+.

Authors:  Cristina Bolzati; Mario Cavazza-Ceccato; Stefania Agostini; Shinji Tokunaga; Dario Casara; Giuliano Bandoli
Journal:  J Nucl Med       Date:  2008-07-16       Impact factor: 10.057

10.  MO tripeptide diastereomers (M=99/99mTc, Re): models to identify the structure of 99mTc peptide targeted radiopharmaceuticals.

Authors:  Melchor V Cantorias; Robertha C Howell; Louis Todaro; John E Cyr; Dietmar Berndorff; Robin D Rogers; Lynn C Francesconi
Journal:  Inorg Chem       Date:  2007-08-11       Impact factor: 5.165

View more
  8 in total

1.  Coordination chemistry of [Y(pypa)]- and comparison immuno-PET imaging of [44Sc]Sc- and [86Y]Y-pypa-phenyl-TRC105.

Authors:  Lily Li; María de Guadalupe Jaraquemada-Peláez; Eduardo Aluicio-Sarduy; Xiaozhu Wang; Todd E Barnhart; Weibo Cai; Valery Radchenko; Paul Schaffer; Jonathan W Engle; Chris Orvig
Journal:  Dalton Trans       Date:  2020-04-09       Impact factor: 4.390

2.  Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals.

Authors:  Brian M Zeglis; Jacob L Houghton; Michael J Evans; Nerissa Viola-Villegas; Jason S Lewis
Journal:  Inorg Chem       Date:  2013-12-06       Impact factor: 5.165

3.  Novel rhenium(III, IV, and V) tetradentate N2O2 Schiff base mononuclear and dinuclear complexes.

Authors:  David A Rotsch; Kimberly M Reinig; Eric M Weis; Anna B Taylor; Charles L Barnes; Silvia S Jurisson
Journal:  Dalton Trans       Date:  2013-07-04       Impact factor: 4.390

Review 4.  Bifunctional chelators for radiorhenium: past, present and future outlook.

Authors:  Diana R Melis; Andrew R Burgoyne; Maarten Ooms; Gilles Gasser
Journal:  RSC Med Chem       Date:  2022-01-14

5.  Monooxorhenium(V) complexes with 222-N2S2 MAMA ligands for bifunctional chelator agents: Syntheses and preliminary in vivo evaluation.

Authors:  Dustin Wayne Demoin; Ashley N Dame; William D Minard; Fabio Gallazzi; Gary L Seickman; Tammy L Rold; Nicole Bernskoetter; Michael E Fassbender; Timothy J Hoffman; Carol A Deakyne; Silvia S Jurisson
Journal:  Nucl Med Biol       Date:  2016-08-31       Impact factor: 2.408

Review 6.  Perspectives on metals-based radioimmunotherapy (RIT): moving forward.

Authors:  Jordan M White; Freddy E Escorcia; Nerissa T Viola
Journal:  Theranostics       Date:  2021-04-15       Impact factor: 11.556

7.  PET Imaging of Extracellular pH in Tumors with (64)Cu- and (18)F-Labeled pHLIP Peptides: A Structure-Activity Optimization Study.

Authors:  Dustin Wayne Demoin; Linden C Wyatt; Kimberly J Edwards; Dalya Abdel-Atti; Mirkka Sarparanta; Jacob Pourat; Valerie A Longo; Sean D Carlin; Donald M Engelman; Oleg A Andreev; Yana K Reshetnyak; Nerissa Viola-Villegas; Jason S Lewis
Journal:  Bioconjug Chem       Date:  2016-07-21       Impact factor: 4.774

Review 8.  Methods to Enhance the Metabolic Stability of Peptide-Based PET Radiopharmaceuticals.

Authors:  Brendan J Evans; Andrew T King; Andrew Katsifis; Lidia Matesic; Joanne F Jamie
Journal:  Molecules       Date:  2020-05-14       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.